Loading...
Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006.
Long, G ; Robert, C ; Arance, A ; Blank, C ; Ribas, A ; Lorigan, Paul C ; Mortier, L ; Schachter, J ; Middleton, M ; Neyns, B ... show 5 more
Long, G
Robert, C
Arance, A
Blank, C
Ribas, A
Lorigan, Paul C
Mortier, L
Schachter, J
Middleton, M
Neyns, B
Citations
Altmetric:
Abstract
Description
Date
2017-02
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006. 2017, 72:S128 Eur J Cancer